IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

IDEXX Laboratories, Inc.

Cash and Cash Equivalents

Cash and Cash Equivalents %Chg

Cash and Cash Equivalents Common Size

Marketable Securities

Marketable Securities %Chg

Marketable Securities Common Size

Accounts Receivable, Net

Accounts Receivable, Net %Chg

Accounts Receivable, Net Common Size

Inventories

Inventories %Chg

Inventories Common Size

Deferred Income Tax Assets

Deferred Income Tax Assets %Chg

Deferred Income Tax Assets Common Size

Other Current Assets

Other Current Assets %Chg

Other Current Assets Common Size

Total Current Assets

Total Current Assets %Chg

Total Current Assets Common Size

Property and Equipment, Net

Property and Equipment, Net %Chg

Property and Equipment, Net Common Size

Operating Lease Right-of-Use Assets

Operating Lease Right-of-Use Assets %Chg

Operating Lease Right-of-Use Assets Common Size

Goodwill

Goodwill %Chg

Goodwill Common Size

Intangible Assets, Net

Intangible Assets, Net %Chg

Intangible Assets, Net Common Size

Other Long-Term Assets

Other Long-Term Assets %Chg

Other Long-Term Assets Common Size

Total Long-Term Assets

Total Long-Term Assets %Chg

Total Long-Term Assets Common Size

Total Assets

Total Assets %Chg

Total Assets Common Size

Accounts Payable

Accounts Payable %Chg

Accounts Payable Common Size

Accrued Liabilities

Accrued Liabilities %Chg

Accrued Liabilities Common Size

Credit Facility

Credit Facility %Chg

Credit Facility Common Size

Current Portion of Long-Term Debt

Current Portion of Long-Term Debt %Chg

Current Portion of Long-Term Debt Common Size

Current Portion of Deferred Revenue

Current Portion of Deferred Revenue %Chg

Current Portion of Deferred Revenue Common Size

Total Current Liabilities

Total Current Liabilities %Chg

Total Current Liabilities Common Size

Deferred Income Tax Liabilities

Deferred Income Tax Liabilities %Chg

Deferred Income Tax Liabilities Common Size

Long-Term Debt, Net of Current Portion

Long-Term Debt, Net of Current Portion %Chg

Long-Term Debt, Net of Current Portion Common Size

Deferred Revenue, Net of Current Portion

Deferred Revenue, Net of Current Portion %Chg

Deferred Revenue, Net of Current Portion Common Size

Operating Lease Liabilities, Net of Current Portion

Operating Lease Liabilities, Net of Current Portion %Chg

Operating Lease Liabilities, Net of Current Portion Common Size

Other Long-Term Liabilities

Other Long-Term Liabilities %Chg

Other Long-Term Liabilities Common Size

Total Long-Term Liabilities

Total Long-Term Liabilities %Chg

Total Long-Term Liabilities Common Size

Total Stockholders' Equity

Total Stockholders' Equity %Chg

Total Stockholders' Equity Common Size

Total Liabilities

Total Liabilities %Chg

Total Liabilities Common Size

Common Stock

Common Stock %Chg

Common Stock Common Size

Additional Paid-in Capital

Additional Paid-in Capital %Chg

Additional Paid-in Capital Common Size

Deferred Stock Units

Deferred Stock Units %Chg

Deferred Stock Units Common Size

Retained Earnings

Retained Earnings %Chg

Retained Earnings Common Size

Accumulated Other Comprehensive Loss

Accumulated Other Comprehensive Loss %Chg

Accumulated Other Comprehensive Loss Common Size

Treasury Stock, at Cost

Short-Term Investments

Short-Term Investments %Chg

Short-Term Investments Common Size

Total Cash and Cash Equivalents

Total Cash and Cash Equivalents %Chg

Total Cash and Cash Equivalents Common Size

Accounts Receivable

Accounts Receivable %Chg

Accounts Receivable Common Size

Total Trade Receivables

Total Trade Receivables %Chg

Total Trade Receivables Common Size

Net Property, Plant & Equipment

Net Property, Plant & Equipment %Chg

Net Property, Plant & Equipment Common Size

Net Intangible Assets

Net Intangible Assets %Chg

Net Intangible Assets Common Size

Accrued Expenses

Accrued Expenses %Chg

Accrued Expenses Common Size

Short-Term Debt

Short-Term Debt %Chg

Short-Term Debt Common Size

Revenue

EBIT

EBITDA

CapEx

Net Interest Income

Assets

Adjusted EBITDA

Gross Profit

Adjusted Net Income

Net Revenue

Net Income

Average Assets

Adjusted EBIT

Adjusted Revenue

Adjusted EBT

Adjusted Funds From Operations

Assets	Jun '25	Dec '24	Jun '24	Dec '23	Jun '23	Dec '22
Cash and Cash Equivalents	164.6	288.3	401.6	453.9	132.8	112.5
Cash and Cash Equivalents
Short-Term Investments	—	—	—	—	—	—
Marketable Securities
Total Cash and Cash Equivalents	164.6	288.3	401.6	453.9	132.8	112.5
Accounts Receivable	560.6	473.6	533.6	457.4	461.9	400.6
Accounts Receivable, Net
Total Trade Receivables	560.6	473.6	533.6	457.4	461.9	400.6
Inventories	392.6	381.9	380	380.3	395.1	367.8
Inventories
Other Current Assets	244.6	256.2	213.5	203.6	189.2	220.5
Deferred Income Tax Assets
Other Current Assets
Total Current Assets	1,362.4	1,399.9	1,528.6	1,495.3	1,179	1,101.5
Total Current Assets
Net Property, Plant & Equipment	869.5	829.3	827.7	817.7	797.4	768.1
Property and Equipment, Net
Operating Lease Right-of-Use Assets
Net Intangible Assets	103.7	111.7	110.8	84.5	90.9	97.7
Intangible Assets, Net
Goodwill	414.5	405.1	408	366	364.2	361.8
Goodwill
Other Long-Term Assets	580.8	547.5	539.7	496.5	439.2	417.7
Other Long-Term Assets
Total Assets	3,330.8	3,293.4	3,414.9	3,259.9	2,870.8	2,746.8
Total Assets

Liabilities	Jun '25	Dec '24	Jun '24	Dec '23	Jun '23	Dec '22
Accounts Payable	116.6	114.2	117.5	110.6	107.7	110.2
Accounts Payable
Accrued Expenses	417	502.1	541.1	478.7	399.4	433.7
Accrued Liabilities
Short-Term Debt	579	250	250	250	264	579
Credit Facility
Current Portion of Long-Term Debt	75	167.8	170.1	75	75	75
Current Portion of Long-Term Debt
Unearned Revenue	36.3	33.8	38	37.2	37.8	37.9
Current Portion of Deferred Revenue
Total Current Liabilities	1,223.9	1,067.9	1,116.7	951.5	883.9	1,235.8
Total Current Liabilities
Long-Term Debt	449.8	449.8	524.7	622.9	696.8	694.4
Long-Term Debt, Net of Current Portion
Leases	107.6	97.8	103	99.7	97.3	101.2
Operating Lease Liabilities, Net of Current Portion
Other Long-Term Liabilities	90.6	82.6	90.2	101.3	98.9	75.7
Deferred Income Tax Liabilities
Deferred Revenue, Net of Current Portion
Other Long-Term Liabilities
Total Long-Term Liabilities	648.1	630.2	717.9	823.8	893.1	902.2
Total Long-Term Liabilities
Total Liabilities	1,872	1,698.1	1,834.6	1,775.4	1,776.9	2,138
Total Liabilities

Equity	Jun '25	Dec '24	Jun '24	Dec '23	Jun '23	Dec '22
Common Stock	10.8	10.8	10.8	10.8	10.7	10.7
Common Stock
Treasury Stock	-6,077.8	-5,334	-4,860.1	-4,474.7	-4,401.7	-4,392.1
Treasury Stock, at Cost
Additional Paid-in Capital	1,733.6	1,679.7	1,631.3	1,575.1	1,520.7	1,468.4
Additional Paid-in Capital
Deferred Stock Units
Accumulated Other Comprehensive Income	-77	-93.6	-85.2	-71.2	-73.7	-77.8
Accumulated Other Comprehensive Loss
Retained Earnings	5,869.1	5,332.4	4,883.4	4,444.6	4,037.8	3,599.5
Retained Earnings
Total Common Shareholders' Equity	1,458.8	1,595.3	1,580.3	1,484.5	1,093.9	608.7
Total IDEXX Laboratories, Inc. Stockholders' Equity
Minority Interests and Other	—	—	—	—	—	—
Noncontrolling Interest
Total Shareholders' Equity	1,458.8	1,595.3	1,580.3	1,484.5	1,093.9	608.7
Total Stockholders' Equity
Total Stockholders' Equity
Total Liabilities and Shareholders' Equity	3,330.8	3,293.4	3,414.9	3,259.9	2,870.8	2,746.8
Total Liabilities and Stockholders' Equity